Search results
Results from the WOW.Com Content Network
Thalidomide, sold under the brand ... Robert D'Amato, who was looking for angiogenesis inhibitors, discovered in 1994 that thalidomide inhibited angiogenesis [70] ...
Feet of a baby born to a mother who had taken thalidomide while pregnant. In the late 1950s and early 1960s, the use of thalidomide in 46 countries was prescribed to women who were pregnant or who subsequently became pregnant, and consequently resulted in the "biggest anthropogenic medical disaster ever," with more than 10,000 children born with a range of severe deformities, such as ...
Frances Kathleen Oldham Kelsey CM (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American [1] pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. [2]
The parent compound of pomalidomide, thalidomide, was originally discovered to inhibit angiogenesis in 1994. [16] Based upon this discovery, thalidomide was taken into clinical trials for cancer, leading to its ultimate FDA approval for multiple myeloma. [17]
McBride published a letter in The Lancet, in December 1961, noting a large number of birth defects in children of patients who were prescribed thalidomide, [9] after a midwife named Sister Pat Sparrow first suspected the drug was causing birth defects in the babies of patients under his care at Crown Street Women's Hospital in Sydney. [10]
In 1970, about 10 years after thalidomide was withdrawn from sale, McCredie was asked whether X-rays could help determine who were true thalidomide victims entitled to compensation from the manufacturer. During her investigations, she observed the way in which thalidomide caused malformations and also discovered a new mechanism of embryogenesis ...
TIL that Thalidomide, the drug responsible for thousands of birth defects across Europe in the 1950s/60s, was developed by a doctor who had previously worked for the Nazis, experimenting on ...
In 1964, Israeli physician Jacob Sheskin discovered the positive effect of thalidomide in the treatment of leprosy. Since the 1970s, Grünenthal has delivered thalidomide tablets to leprosy clinics to cure leprosy. The delivery takes place under strict conditions and by virtue of an agreement with the World Health Organization. [21]